To investigate whether levels of active AEP would increase in BSSM treated ApoE-KO mice with severe atherosclerosis, we evaluated the expression of AEP and the alteration of tau N368 truncated by active-AEP. The gene discussed is LGMN; the disease is atherosclerosis.